ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing February 25, 2026 VH184, the first, third‑generation integrase inhibitor in development shows potential for up to twice-yearly dosing intervals Additional in-vitro data on VH184 demonstrate improved potency and an enhanced resistance profile versus bictegravir VH499 demonstrates good tolerability, supporting twice-yearly dosing intervals
Extend Launches CIP: a Cultural Intelligence Platform Empowering Marketers to Plan, Manage, and Monitor Campaigns Directly Through Its Marketing Platform February 25, 2026 Extend CIP unifies years of product and agency experience into a single platform for marketers across the Arab world, launching with the region's largest influencer ad library and end-to-end campaign tools
Orbia Announces CFO Transition and Appointment of Successor February 25, 2026 Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) (“Orbia” or “the Company”) announced today that James P. “Jim” Kelly will retire as Chief Financial Officer after four years of service. The Company also announced that Cristian “Cape” Capellino will assume the role of Chief Financial Officer effective March 15, 2026. Kelly joined Orbia in 2021 [...]
Aera Technology Named to The Hackett Group® 2025–2026 “50 to Watch” List for Procurement Innovation February 25, 2026 Recognized for Enabling Real-Time Procurement Decisions Across the Enterprise
Alkermes plc Announces CEO Succession Plan February 25, 2026 — Richard Pops to Retire from Role of Chief Executive Officer Following Distinguished 35-year Career with Alkermes — — Board of Directors Appointed Blair Jackson, Alkermes’ Current Executive Vice President, Chief Operating Officer, as CEO Effective as of August 1, 2026 — — Richard Pops to Continue to Serve as Chairman of the Alkermes Board of Directors —
Chemify and Sanacor Collaborate to Discover and Develop Small Molecule Therapies for Cardiometabolic Diseases February 25, 2026 Partnership to use Chemify’s programmable chemistry technology and Sanacor’s translational biology expertise to accelerate small-molecule discovery addressing mitochondrial dysfunction
John Lewis blames high costs as it axes build-to-rent venture February 25, 2026 Retail giant John Lewis is to withdraw from its build-to-rent business in a shock U-turn on its diversification plans, after bemoaning high interest rates and a downturn in the London property market. John Lewis Partnership (JLP), which also owns Waitrose, took on management of around 1,000 homes in Bromley, West Ealing and Reading as part [...]
Bureau Veritas: Sector-Leading Organic Revenue Growth of 6.5% in FY 2025 February 25, 2026 Strong margin improvement to 16.3% in FY 2025 Positive growth outlook with continued margin expansion in 2026 New EUR 200 million share buyback
Small business minister: we will unlock £1bn of local lending February 25, 2026 Community Development Finance gives small local business the funding and confidence they need to grow. That’s why this Labour government is launching a taskforce to expand the sector, say Blair McDougall and Bob Annibale The UK has long been home to an entrepreneurial spirit of creativity and innovation, from household names to neighbourhood heroes. Despite [...]
Pro Climbing League leans into urban boom ahead of sold-out London launch February 24, 2026 When the first batch of tickets for the London launch event of the Pro Climbing League went on sale last month they sold out in five minutes. Not quite Oasis or Taylor Swift levels of devotion, but for a minority sport with little history as a spectator event, impressive nonetheless. On Saturday night at Magazine [...]